These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9787993)

  • 1. Current research and future developments in retinoids: oral and topical agents.
    Chandraratna RA
    Cutis; 1998 Feb; 61(2 Suppl):40-5. PubMed ID: 9787993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.
    Chandraratna RA
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S12-7. PubMed ID: 9270551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The retinoid receptors.
    Pemrick SM; Lucas DA; Grippo JF
    Leukemia; 1994 Nov; 8(11):1797-806. PubMed ID: 7967725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
    Elmazar MM; Reichert U; Shroot B; Nau H
    Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoid receptors.
    Pemrick SM; Lucas DA; Grippo JF
    Leukemia; 1994; 8 Suppl 3():S1-10. PubMed ID: 7808017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor specificity of retinoid-induced epidermal hyperplasia: effect of RXR-selective agonists and correlation with topical irritation.
    Thacher SM; Standeven AM; Athanikar J; Kopper S; Castilleja O; Escobar M; Beard RL; Chandraratna RA
    J Pharmacol Exp Ther; 1997 Aug; 282(2):528-34. PubMed ID: 9262312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retinoid signalling pathways].
    Fukasawa H; Shudo K
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):555-66. PubMed ID: 8470912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
    Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
    Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future trends: a new generation of retinoids.
    Chandraratna RA
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S149-52. PubMed ID: 9777794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-selective retinoid agonists and teratogenic activity.
    Willhite CC; Dawson MI; Reichert U
    Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in receptor-selective retinoids.
    Nagpal S; Chandraratna RA
    Curr Pharm Des; 2000 Jun; 6(9):919-31. PubMed ID: 10828316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
    Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
    J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids.
    Bikowski JB
    J Drugs Dermatol; 2005; 4(1):41-7. PubMed ID: 15696984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments in topical retinoid therapy for acne.
    Bershad S
    Semin Cutan Med Surg; 2001 Sep; 20(3):154-61. PubMed ID: 11594670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoids--which dermatological indications will benefit in the near future?
    Zouboulis CC
    Skin Pharmacol Appl Skin Physiol; 2001; 14(5):303-15. PubMed ID: 11586072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tazarotene--first of a new generation of receptor-selective retinoids.
    Chandraratna RA
    Br J Dermatol; 1996 Oct; 135 Suppl 49():18-25. PubMed ID: 9035701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.
    Beard RL; Colon DF; Song TK; Davies PJ; Kochhar DM; Chandraratna RA
    J Med Chem; 1996 Aug; 39(18):3556-63. PubMed ID: 8784454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin.
    Nagpal S; Patel S; Jacobe H; DiSepio D; Ghosn C; Malhotra M; Teng M; Duvic M; Chandraratna RA
    J Invest Dermatol; 1997 Jul; 109(1):91-5. PubMed ID: 9204961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.